NCT06815315 is a NA clinical trial of Multiple micronutrient supplementation in Anemia, sponsored by World Vision US.

Who is sponsoring NCT06815315?

NCT06815315 is sponsored by World Vision US.

What drugs are being tested in NCT06815315?

Interventions in NCT06815315: Multiple micronutrient supplementation, Iron Folic Acid Supplementation, Adolescent Nutrition Curriculum.

Is NCT06815315 still recruiting?

NCT06815315 is currently completed. Last updated 7 February 2025.

Last reviewed 2025-02-07 · How we verify

NCT06815315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating of the Impact of Micronutrient Interventions Among Adolescents in Mozambique

Completed NA Last updated 7 February 2025

What this trial tests

NA trial testing Multiple micronutrient supplementation in Anemia in 490 participants. Completed in 31 December 2024.

Timeline

1 January 2024

Primary endpoint
30 September 2024

31 December 2024

Quick facts

Lead sponsor	World Vision US
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	490
Start date	1 January 2024
Primary completion	30 September 2024
Estimated completion	31 December 2024
Sites	1 location across Mozambique

Drugs / interventions tested

Multiple micronutrient supplementation — full drug profile →
Iron Folic Acid Supplementation
Adolescent Nutrition Curriculum

Conditions studied

Anemia — all drugs for Anemia →

Sponsor

World Vision US

Who can join

Adults 13 to 20, female only, with Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This purpose of this study is to assess effects of iron and folic acid supplementation and multiple micronutrient supplementation on anemia status and the impact of a nutrition curriculum on diet diversity and anemia knowledge among adolescent girls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06815315 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by World Vision US
Last refreshed: 7 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06815315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing